Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Salloway

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2025
Biomarker changes associated with fornix deep brain stimulation in Alzheimer's diseaseJürgen Germann, Robert S C Amaral, Jennifer Tomaszczyk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2023
Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER)Laura D Baker, Heather M Snyder, Mark A Espeland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2026
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADSDustin B Hammers, Elodie Foster, Ani Eloyan, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
The Lancet. Neurology|February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyBrian A Gordon, Tyler M Blazey, Yi Su, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 24, 2022
Pattern and implications of neurological examination findings in autosomal dominant Alzheimer diseaseJonathan Vöglein, Nicolai Franzmeier, John C Morris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2023
Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohortKelly N H Nudelman, Trever Jackson, Malia Rumbaugh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2025
Biomarker changes associated with fornix deep brain stimulation in Alzheimer's diseaseJürgen Germann, Robert S C Amaral, Jennifer Tomaszczyk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2023
Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER)Laura D Baker, Heather M Snyder, Mark A Espeland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2026
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADSDustin B Hammers, Elodie Foster, Ani Eloyan, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
The Lancet. Neurology|February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyBrian A Gordon, Tyler M Blazey, Yi Su, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 24, 2022
Pattern and implications of neurological examination findings in autosomal dominant Alzheimer diseaseJonathan Vöglein, Nicolai Franzmeier, John C Morris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2023
Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohortKelly N H Nudelman, Trever Jackson, Malia Rumbaugh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Pageof 18